UK MHRA: Information sent to HCPs in April 2014 about the safety of medicines

Please see the following letter sent to healthcare professionals from the MHRA:

• Domperidone: risk of cardiac side effects – restricted indication, new contraindications, and reduced dose and duration of use

There were no letters sent to healthcare professionals by licence-holders in April.

 

Posted on the UK MHRA website on 7 May 2014